![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/lighthouse-pharmaceuticals-announces-fda-approval-to-proceed-with-phase-2-spring-trial-of-lhp588-a-next-generation-treatment-for-p-gingivalis-positive-alzheimers-disease-301990086.html
https://www.prnewswire.com/news-releases/lighthouse-pharmaceuticals-announces-presentation-at-the-2023-american-society-of-clinical-psychopharmacology-ascp-annual-meeting-301832708.html
https://www.prnewswire.com/news-releases/lighthouse-pharmaceuticals-announces-progression-of-lhp588-clinical-development-program-in-alzheimers-disease-301820267.html